Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, April 23, 2010

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.



CONCLUSION: Although dictated family history was accurate, interpretation of risk for BRCA1 or BRCA2 mutations and subsequent referral to genetic counseling was poor. Although there was significant improvement over time, 50% of substantial-risk patients still were missed. Systematic efforts to identify those ovarian cancer patients at substantial risk for a BRCA1 or BRCA2 are necessary.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.